{
  "id": 16579623,
  "title": "Pharma: Bayer's Xarelto successor Asundexian approved in China",
  "url": "https://urgent.news/2026/10/26/pharma-bayers-xarelto-nachfolger-asundexian-in-china-zugelassen",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T08:56:00.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/pharma-bayers-xarelto-nachfolger-asundexian-in-china-zugelassen/100264912.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "Bayer receives green light in China for new stroke protection. Asundexian is the first drug of a new class of anticoagulants approved there.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}